Clinical Trial Details
EORTC-26062-22061
Back to Clinical Trials Database
A randomized phase III study of Temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 31-Aug-2009 Date Step1 close: 19-Sep-2013 |
Data management at EORTC | No |
Design |
Phase 3 Randomized open label |
Targeted Sample size | EORTC Groups: 200 - All Groups: 560 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/NCT00482677 |
NCT number | NCT00482677 |
EudraCT | 2008-001949-26 |